Shares outstanding increased 660.0%
Shares outstanding changed +660.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +660.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed -61.1% from the comparable as-filed period.
Research & development changed +117.3% from the comparable as-filed period.
Net income changed -41.9% from the comparable as-filed period.
Free-cash-flow proxy changed -16.6% from the comparable as-filed period.
Operating cash flow changed -16.7% from the comparable as-filed period.
Cash & equivalents changed -35.7% from the comparable as-filed period.
Current liabilities changed +84.9% from the comparable as-filed period.
Capital expenditure changed -100.0% from the comparable as-filed period.
Current ratio changed -61.4% from the comparable as-filed period.
Stock-based compensation changed +432.4% from the comparable as-filed period.
Working capital / assets changed -5879 basis points from the comparable as-filed period.
Current assets changed -28.6% from the comparable as-filed period.
Total assets changed -26.8% from the comparable as-filed period.
Working capital changed -107.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.